Crossmark

Knockdown of circ_0003928 ameliorates high glucose-induced dysfunction of human tubular epithelial cells through the miR-506-3p/HDAC4 pathway in diabetic nephropathy

Crossref DOI link: https://doi.org/10.1186/s40001-022-00679-y

Published Online: 2022-04-07

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Qiong

Cui, Yuanyuan

Ding, Nan

Zhou, Changxue
License Information

Text and Data Mining valid from 2022-04-07

Version of Record valid from 2022-04-07
More Information

Article History

Received: 10 January 2022

Accepted: 20 March 2022

First Online: 7 April 2022

Declarations

:

: The clinical trial obtained approval from the Ethics Committee of Hebei General Hospital and was carried out according to the guidelines of Declaration of Helsinki.

: Not applicable.

: The authors report no conflicts of interest.

Document is current

Any future updates will be listed below